The future of pharmaceutical facilities is linked to digitalization, which serves as the foundation for leveraging data ...

Discover how Under Armour turns athlete insights and rapid prototyping into marathon-winning supershoes—learn how your next ...

Every few years, a new sensing capability reshapes an entire product category. Brain data is next, and this time, most ...

Tetra Sciborgs, a team of scientist-engineers who operate at the nexus of science, data, and AI, will be forward-deployed to guide Syngenta through implementation, adoption, and continuous improvement ...

GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

Conspiracies are running rampant online after the deaths or disappearances of at least 10 people tied to sensitive US ...

Finding the right people for critical open roles can be difficult even for biopharma leaders. In this column, Kaye/Bassman’s ...

Chelsea Lodewyk from Publicis Commerce / Digitas gives insight into why belief, not just performance, is becoming the most ...

On April 17, my mother turned 88. To me, her life represents an 88-year masterclass in work ethic, human capital development, and the eventual transition ...

In this excerpt from “We Are As Gods: A Survival God for the Age of Abundance,” authors Peter H. Diamandis and Steven Kotler ...

Getting a drug from initial target discovery to U.S. regulatory approval takes between 10 and 15 years on average. Most of ...

Global counter-drone spending is entering a structural acceleration. According to MarketsandMarkets, the Counter-Unmanned Aircraft Systems (C-UAS) market is estimated at USD 6.64 billion in 2025 and ...